Cencora Trading Volume Plummets 31.17% to 3.67 Billion, Slips to 232nd in Market Rankings
1min read On April 1, 2025, cencora (COR) experienced a significant decline, with its trading volume dropping by 31.17% to 3.67 billion, placing it at the 232nd position in the day's stock market rankings. The stock price of Cencora decreased by 0.24%.
Cencora, Inc. has announced that it will release its Second Quarter Fiscal 2025 financial results on Wednesday, May 7, 2025. This announcement is significant as it provides investors with a clear timeline for the company's upcoming earnings report, which is crucial for assessing the company's financial health and future prospects.
Cencora is one of the leading pharmaceutical wholesalers in the United States, alongside McKesson and Cardinal Health, collectively dominating over 90% of the US pharmaceutical wholesale industry. The company sources and distributes a wide range of pharmaceutical products, including branded, generic, and specialty pharmaceuticals, to various healthcare providers. Additionally, Cencora offers commercialization services for pharmaceutical and medical device manufacturers, global specialty drug logistics through World Courier, and animal health product distribution via MWI Animal Health. In 2021, Cencora expanded its international presence by acquiring Alliance Healthcare, a prominent drug wholesaler in Europe.
